Literature DB >> 10815679

Iatrogenic arterial spasm relieved by intraarterial mannitol infusion.

D Fortin1, E Osztie, E A Neuwelt.   

Abstract

Catheter placement for blood brain-barrier disruption and enhanced chemotherapy delivery can sometimes trigger arterial spasm of moderate-to-severe degree. A slow infusion of a small quantity of intraarterially administered mannitol (10 mL of 25% mannitol) was evaluated as a means to obtain a rapid resolution of catheter placement-induced spasm. We prospectively report 12 consecutive cases of blood brain-barrier disruption among patients who developed catheter placement-induced spasm that was treated by this means without side effects, resulting in rapid resolution of spasm.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815679      PMCID: PMC7976766     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  12 in total

Review 1.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

Authors:  R A Kroll; E A Neuwelt
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

2.  Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

Authors:  N D Doolittle; M E Miner; W A Hall; T Siegal; E Jerome; E Osztie; L D McAllister; J S Bubalo; D F Kraemer; D Fortin; R Nixon; L L Muldoon; E A Neuwelt
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

3.  Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm.

Authors:  M Sawada; N Hashimoto; T Tsukahara; S Nishi; Y Kaku; S Yoshimura
Journal:  Acta Neurochir (Wien)       Date:  1997       Impact factor: 2.216

4.  Quantification and predictors of plasma volume expansion from mannitol treatment.

Authors:  P M Ambühl; P E Ballmer; S Krähenbühl; R Krapf
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

5.  Intraarterial infusion of papaverine in experimental cerebral vasospasm.

Authors:  N Fujiwara; Y Honjo; M Ohkawa; M Tanabe; K Irie; S Nagao; H Takashima; K Satoh; K Kojima
Journal:  AJNR Am J Neuroradiol       Date:  1997-02       Impact factor: 3.825

6.  Polyols that accumulate in renal tissue uncouple the plasma membrane calcium pump and counteract the inhibition by urea and guanidine hydrochloride.

Authors:  M Sola-Penna; A dos P Lemos; M P Fávero-Retto; J R Meyer-Fernandes; A Vieyra
Journal:  Z Naturforsch C J Biosci       Date:  1995 Jan-Feb

7.  Effect of mannitol on the permeability of cultured endothelial cells.

Authors:  T Machi; N F Kassell; M W Scheld; G A Lehmann
Journal:  Fukuoka Igaku Zasshi       Date:  1996-08

8.  Treatment of traumatic arterial vasospasm with intraarterial papaverine infusion.

Authors:  A B Vardiman; T A Kopitnik; P D Purdy; H H Batjer; D S Samson
Journal:  AJNR Am J Neuroradiol       Date:  1995-02       Impact factor: 3.825

9.  Effects of mannitol on cultured corneal endothelial cell Na,K-ATPase activity.

Authors:  D R Whikehart; P Angelos; B Montgomery
Journal:  Cornea       Date:  1995-05       Impact factor: 2.651

10.  Extracranial intravascular vasodilatory response to acetazolamide and magnetic resonance angiography.

Authors:  R L Levine; P A Turski; W D Turnipseed; T Grist
Journal:  J Neuroimaging       Date:  1996-04       Impact factor: 2.486

View more
  2 in total

Review 1.  Intracarotid delivery of drugs: the potential and the pitfalls.

Authors:  Shailendra Joshi; Phillip M Meyers; Eugene Ornstein
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

2.  Treatment of mechanically-induced vasospasm of the carotid artery in a primate using intra-arterial verapamil: a technical case report.

Authors:  Alexander L Coon; Geoffrey P Colby; William J Mack; Lei Feng; Philip Meyers; E Sander Connolly
Journal:  BMC Cardiovasc Disord       Date:  2004-07-21       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.